| Year |
Citation |
Score |
| 2024 |
Sayedahmed EE, Elshafie NO, Dos Santos AP, Jagannath C, Sambhara S, Mittal SK. Development of NP-Based Universal Vaccine for Influenza A Viruses. Vaccines. 12. PMID 38400140 DOI: 10.3390/vaccines12020157 |
0.78 |
|
| 2023 |
Sayedahmed EE, Elshafie NO, Zhang G, Mohammed SI, Sambhara S, Mittal SK. Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector. Frontiers in Immunology. 14: 1305937. PMID 38077380 DOI: 10.3389/fimmu.2023.1305937 |
0.799 |
|
| 2023 |
Sayedahmed EE, Araújo MV, Silva-Pereira TT, Chothe SK, Elkashif A, Alhashimi M, Wang WC, Santos AP, Nair MS, Gontu A, Nissly R, Francisco de Souza Filho A, Tavares MS, Ayupe MC, Salgado CL, ... ... Mittal SK, et al. Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine. Molecular Therapy. Methods & Clinical Development. 30: 194-207. PMID 37502665 DOI: 10.1016/j.omtm.2023.06.009 |
0.798 |
|
| 2022 |
Wang WC, Sayedahmed EE, Mittal SK. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy. Viruses. 14. PMID 36560730 DOI: 10.3390/v14122727 |
0.789 |
|
| 2022 |
Wang WC, Sayedahmed EE, Sambhara S, Mittal SK. Progress towards the Development of a Universal Influenza Vaccine. Viruses. 14. PMID 36016306 DOI: 10.3390/v14081684 |
0.811 |
|
| 2021 |
Elkashif A, Alhashimi M, Sayedahmed EE, Sambhara S, Mittal SK. Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections. Clinical & Translational Immunology. 10: e1345. PMID 34667600 DOI: 10.1002/cti2.1345 |
0.814 |
|
| 2021 |
Khan A, Sayedahmed EE, Singh VK, Mishra A, Dorta-Estremera S, Nookala S, Canaday DH, Chen M, Wang J, Sastry KJ, Mittal SK, Jagannath C. A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice. Cell Reports. Medicine. 2: 100372. PMID 34467249 DOI: 10.1016/j.xcrm.2021.100372 |
0.777 |
|
| 2021 |
Alhashimi M, Elkashif A, Sayedahmed EE, Mittal SK. Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases. Viruses. 13. PMID 34452358 DOI: 10.3390/v13081493 |
0.795 |
|
| 2021 |
Bohannon CD, Ende Z, Cao W, Mboko WP, Ranjan P, Kumar A, Mishina M, Amoah S, Gangappa S, Mittal SK, Lovell JF, García-Sastre A, Pfeifer BA, Davidson BA, Knight P, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2100693. PMID 34189857 DOI: 10.1002/advs.202100693 |
0.399 |
|
| 2020 |
Sayedahmed EE, Elkashif A, Alhashimi M, Sambhara S, Mittal SK. Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines. Vaccines. 8. PMID 33019589 DOI: 10.3390/vaccines8040574 |
0.809 |
|
| 2020 |
Sayedahmed EE, Mittal SK. A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations. Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire. 84: 314-318. PMID 33012981 |
0.765 |
|
| 2019 |
Sayedahmed EE, Kumari R, Mittal SK. Current Use of Adenovirus Vectors and Their Production Methods. Methods in Molecular Biology (Clifton, N.J.). 1937: 155-175. PMID 30706395 DOI: 10.1007/978-1-4939-9065-8_9 |
0.778 |
|
| 2018 |
Sayedahmed EE, Kumari R, Shukla S, Hassan AO, Mohammed SI, York IA, Gangappa S, Sambhara S, Mittal SK. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy. Vaccine. PMID 30266488 DOI: 10.1016/J.Vaccine.2018.09.031 |
0.834 |
|
| 2018 |
Sayedahmed EE, Hassan AO, Kumari R, Cao W, Gangappa S, York I, Sambhara S, Mittal SK. A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose. Molecular Therapy. Methods & Clinical Development. 10: 210-222. PMID 30101154 DOI: 10.1016/J.Omtm.2018.07.007 |
0.833 |
|
| 2018 |
Cao W, Mishina M, Amoah S, Mboko WP, Bohannon C, McCoy J, Mittal SK, Gangappa S, Sambhara S. Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEIinduces enhanced serological, cellular and protective immune responses. Drug Delivery. 25: 773-779. PMID 29542358 DOI: 10.1080/10717544.2018.1450909 |
0.543 |
|
| 2017 |
Hassan AO, Amen O, Sayedahmed EE, Vemula SV, Amoah S, York I, Gangappa S, Sambhara S, Mittal SK. Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses. Plos One. 12: e0186244. PMID 29023601 DOI: 10.1371/Journal.Pone.0186244 |
0.814 |
|
| 2017 |
Vemula SV, Sayedahmed EE, Sambhara S, Mittal SK. Vaccine approaches conferring cross-protection against influenza viruses. Expert Review of Vaccines. 1-14. PMID 28925296 DOI: 10.1080/14760584.2017.1379396 |
0.819 |
|
| 2017 |
Ahi YS, Hassan AO, Vemula SV, Li K, Jiang W, Zhang GJ, Mittal SK. Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal. Scientific Reports. 7: 7582. PMID 28790440 DOI: 10.1038/S41598-017-07997-W |
0.689 |
|
| 2017 |
Hassan AO, Vemula SV, Sharma A, Bangari DS, Mishra KK, Mittal SK. 155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication. The Journal of General Virology. PMID 28086071 DOI: 10.1099/Jgv.0.000707 |
0.73 |
|
| 2016 |
Cao W, Liepkalns J, Hassan AO, Kamal R, Hofstetter AR, Amoah S, Kim JH, Reber A, Stevens J, Katz JM, Gangappa S, York I, Mittal SK, Sambhara S. A highly immunogenic vaccine against A(H7N9) influenza virus. Vaccine. PMID 26765287 DOI: 10.1016/J.Vaccine.2015.12.062 |
0.567 |
|
| 2016 |
Mittal SK, Ahi YS, Vemula SV. Xenogenic Adenoviral Vectors Adenoviral Vectors For Gene Therapy: Second Edition. 495-528. DOI: 10.1016/B978-0-12-800276-6.00019-X |
0.769 |
|
| 2015 |
Amen O, Vemula SV, Zhao J, Ibrahim R, Hussein A, Hewlett IK, Moussa S, Mittal SK. Identification and characterization of a highly pathogenic H5N1 avian influenza A virus during an outbreak in vaccinated chickens in Egypt. Virus Research. 210: 337-43. PMID 26363196 DOI: 10.1016/J.Virusres.2015.09.004 |
0.789 |
|
| 2015 |
Sharma A, Clark E, McGlothlin JD, Mittal SK. Efficiency of Airborne Sample Analysis Platform (ASAP) bioaerosol sampler for pathogen detection. Frontiers in Microbiology. 6: 512. PMID 26074900 DOI: 10.3389/Fmicb.2015.00512 |
0.504 |
|
| 2015 |
Ahi YS, Vemula SV, Hassan AO, Costakes G, Stauffacher C, Mittal SK. Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging. Frontiers in Microbiology. 6: 318. PMID 25954255 DOI: 10.3389/Fmicb.2015.00318 |
0.7 |
|
| 2013 |
Vemula SV, Amen O, Katz JM, Donis R, Sambhara S, Mittal SK. Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time. Virus Research. 178: 398-403. PMID 24051000 DOI: 10.1016/J.Virusres.2013.09.013 |
0.807 |
|
| 2013 |
Vemula SV, Pandey A, Singh N, Katz JM, Donis R, Sambhara S, Mittal SK. Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice. Virus Research. 177: 55-61. PMID 23892144 DOI: 10.1016/J.Virusres.2013.07.008 |
0.797 |
|
| 2013 |
Vemula SV, Ahi YS, Swaim AM, Katz JM, Donis R, Sambhara S, Mittal SK. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. Plos One. 8: e62496. PMID 23638099 DOI: 10.1371/Journal.Pone.0062496 |
0.795 |
|
| 2013 |
Ahi YS, Vemula SV, Mittal SK. Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein. The Journal of General Virology. 94: 1325-34. PMID 23388198 DOI: 10.1099/Vir.0.049346-0 |
0.712 |
|
| 2012 |
Pandey A, Singh N, Vemula SV, Couëtil L, Katz JM, Donis R, Sambhara S, Mittal SK. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine. Plos One. 7: e33428. PMID 22432020 DOI: 10.1371/Journal.Pone.0033428 |
0.805 |
|
| 2012 |
Tandon M, Vemula SV, Sharma A, Ahi YS, Mittal S, Bangari DS, Mittal SK. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model. The Journal of Gene Medicine. 14: 77-89. PMID 22228563 DOI: 10.1002/Jgm.1649 |
0.716 |
|
| 2012 |
Tandon M, Sharma A, Vemula SV, Bangari DS, Mittal SK. Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer. Virus Research. 163: 202-11. PMID 21971215 DOI: 10.1016/J.Virusres.2011.09.031 |
0.778 |
|
| 2011 |
Sharma A, Bangari DS, Vemula SV, Mittal SK. Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines. Virus Research. 161: 181-7. PMID 21864589 DOI: 10.1016/J.Virusres.2011.08.002 |
0.76 |
|
| 2011 |
Ahi YS, Bangari DS, Mittal SK. Adenoviral vector immunity: its implications and circumvention strategies. Current Gene Therapy. 11: 307-20. PMID 21453277 DOI: 10.2174/156652311796150372 |
0.415 |
|
| 2011 |
Tandon M, Vemula SV, Mittal SK. Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opinion On Therapeutic Targets. 15: 31-51. PMID 21142802 DOI: 10.1517/14728222.2011.538682 |
0.677 |
|
| 2010 |
Vemula SV, Mittal SK. Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opinion On Biological Therapy. 10: 1469-87. PMID 20822477 DOI: 10.1517/14712598.2010.519332 |
0.79 |
|
| 2010 |
Sharma A, Bangari DS, Tandon M, Hogenesch H, Mittal SK. Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model. Virus Research. 153: 134-42. PMID 20659505 DOI: 10.1016/J.Virusres.2010.07.021 |
0.572 |
|
| 2010 |
Singh N, Pandey A, Mittal SK. Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target. Expert Reviews in Molecular Medicine. 12: e14. PMID 20426889 DOI: 10.1017/S1462399410001432 |
0.501 |
|
| 2010 |
Sharma A, Tandon M, Ahi YS, Bangari DS, Vemulapalli R, Mittal SK. Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses. Gene Therapy. 17: 634-42. PMID 20164856 DOI: 10.1038/Gt.2010.1 |
0.547 |
|
| 2010 |
Pandey A, Singh N, Sambhara S, Mittal SK. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. Human Vaccines. 6: 178-88. PMID 19875936 DOI: 10.4161/Hv.6.2.9899 |
0.53 |
|
| 2009 |
Sharma A, Tandon M, Bangari DS, Mittal SK. Adenoviral vector-based strategies for cancer therapy. Current Drug Therapy. 4: 117-138. PMID 20160875 DOI: 10.2174/157488509788185123 |
0.54 |
|
| 2009 |
Sharma A, Li X, Bangari DS, Mittal SK. Adenovirus receptors and their implications in gene delivery. Virus Research. 143: 184-94. PMID 19647886 DOI: 10.1016/J.Virusres.2009.02.010 |
0.524 |
|
| 2009 |
Li X, Bangari DS, Sharma A, Mittal SK. Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry. Virology. 392: 162-8. PMID 19646729 DOI: 10.1016/J.Virol.2009.06.029 |
0.49 |
|
| 2009 |
Bangari DS, Miller MA, Stevenson GW, Thacker HL, Sharma A, Mittal SK. Cutaneous and systemic poxviral disease in red (Tamiasciurus hudsonicus) and gray (Sciurus carolinensis) squirrels. Veterinary Pathology. 46: 667-72. PMID 19276066 DOI: 10.1354/Vp.08-Vp-0305-B-Bc |
0.457 |
|
| 2009 |
Sharma A, Bangari DS, Tandon M, Pandey A, HogenEsch H, Mittal SK. Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model. Virology. 386: 44-54. PMID 19211122 DOI: 10.1016/J.Virol.2009.01.008 |
0.567 |
|
| 2008 |
Hoelscher MA, Singh N, Garg S, Jayashankar L, Veguilla V, Pandey A, Matsuoka Y, Katz JM, Donis R, Mittal SK, Sambhara S. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. The Journal of Infectious Diseases. 197: 1185-8. PMID 18462165 DOI: 10.1086/529522 |
0.521 |
|
| 2008 |
Singh N, Pandey A, Jayashankar L, Mittal SK. Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 965-71. PMID 18301400 DOI: 10.1038/Mt.2008.12 |
0.544 |
|
| 2007 |
Hoelscher MA, Jayashankar L, Garg S, Veguilla V, Lu X, Singh N, Katz JM, Mittal SK, Sambhara S. New pre-pandemic influenza vaccines: An egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice Clinical Pharmacology and Therapeutics. 82: 665-671. PMID 17957181 DOI: 10.1038/Sj.Clpt.6100418 |
0.556 |
|
| 2006 |
Bangari DS, Mittal SK. Current strategies and future directions for eluding adenoviral vector immunity. Current Gene Therapy. 6: 215-26. PMID 16611043 DOI: 10.2174/156652306776359478 |
0.413 |
|
| 2006 |
Hoelscher MA, Garg S, Bangari DS, Belser JA, Lu X, Stephenson I, Bright RA, Katz JM, Mittal SK, Sambhara S. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet (London, England). 367: 475-81. PMID 16473124 DOI: 10.1016/S0140-6736(06)68076-8 |
0.529 |
|
| 2006 |
Bangari DS, Mittal SK. Development of nonhuman adenoviruses as vaccine vectors. Vaccine. 24: 849-62. PMID 16297508 DOI: 10.1016/J.Vaccine.2005.08.101 |
0.539 |
|
| 2006 |
Gil LH, van Olphen AL, Mittal SK, Donis RO. Modulation of PKR activity in cells infected by bovine viral diarrhea virus. Virus Research. 116: 69-77. PMID 16194578 DOI: 10.1016/J.Virusres.2005.08.011 |
0.315 |
|
| 2006 |
Bangari DS, Sharma A, Pandey A, HogenEsch H, Mittal SK. 17. Biodistribution, Innate Immune Response and Toxicity Following Intravenous Inoculation of Mice with Nonhuman Adenoviral Vectors Molecular Therapy. 13: S7. DOI: 10.1016/J.Ymthe.2006.08.028 |
0.552 |
|
| 2005 |
Bangari DS, Sharma A, Mittal SK. Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3. Biochemical and Biophysical Research Communications. 331: 1478-84. PMID 15883040 DOI: 10.1016/J.Bbrc.2005.04.058 |
0.555 |
|
| 2005 |
Bangari DS, Mittal SK. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin. Virology. 332: 157-66. PMID 15661148 DOI: 10.1016/J.Virol.2004.11.010 |
0.386 |
|
| 2005 |
Bangari DS, Shukla S, Mittal SK. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochemical and Biophysical Research Communications. 327: 960-6. PMID 15649439 DOI: 10.1016/J.Bbrc.2004.12.099 |
0.46 |
|
| 2005 |
Noblitt LW, Bangari DS, Shukla S, Mohammed S, Mittal SK. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy. Cancer Gene Therapy. 12: 46-53. PMID 15486559 DOI: 10.1038/Sj.Cgt.7700763 |
0.311 |
|
| 2004 |
Mittal SK, Goel S, Sharma A. Metal ion effect on BOD exertion at different temperatures. International Journal of Environmental Research and Public Health. 1: 132-7. PMID 16696188 |
0.345 |
|
| 2004 |
Noblitt LW, Bangari DS, Shukla S, Knapp DW, Mohammed S, Kinch MS, Mittal SK. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1. Cancer Gene Therapy. 11: 757-66. PMID 15359289 DOI: 10.1038/Sj.Cgt.7700761 |
0.321 |
|
| 2004 |
Bangari DS, Mittal SK. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture. Virus Research. 105: 127-36. PMID 15351486 DOI: 10.1016/J.Virusres.2004.05.003 |
0.466 |
|
| 2004 |
Singh D, Mittal SK. 458. Efficient Transduction of Human and Murine Cells and Circumvention of Preexisting Human Adenoviral Immunity by Porcine Adenoviral Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.421 |
0.63 |
|
| 2002 |
Sailaja G, HogenEsch H, North A, Hays J, Mittal SK. Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response. Gene Therapy. 9: 1722-9. PMID 12457287 DOI: 10.1038/Sj.Gt.3301858 |
0.398 |
|
| 2002 |
van Olphen AL, Mittal SK. Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted. Journal of Virology. 76: 5882-92. PMID 12021321 DOI: 10.1128/Jvi.76.12.5882-5892.2002 |
0.321 |
|
| 2000 |
Mittal SK, Aggarwal N, Sailaja G, van Olphen A, HogenEsch H, North A, Hays J, Moffatt S. Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. Vaccine. 19: 253-63. PMID 10930680 DOI: 10.1016/S0264-410X(00)00170-5 |
0.398 |
|
| 2000 |
Moffatt S, Hays J, HogenEsch H, Mittal SK. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy. Virology. 272: 159-67. PMID 10873758 DOI: 10.1006/Viro.2000.0350 |
0.453 |
|
| 1999 |
van Olphen AL, Mittal SK. Generation of infectious genome of bovine adenovirus type 3 by homologous recombination in bacteria. Journal of Virological Methods. 77: 125-9. PMID 10092136 DOI: 10.1016/S0166-0934(98)00145-1 |
0.349 |
|
| 1998 |
Mittal SK, Tikoo SK, van den Hurk JV, Breker-Klassen MM, Yoo D, Babiuk LA. Functional characterization of bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins expressed by adenovirus recombinants. Intervirology. 41: 253-60. PMID 10325535 DOI: 10.1159/000024947 |
0.389 |
|
| 1998 |
Kiupel M, Stevenson GW, Mittal SK, Clark EG, Haines DM. Circovirus-like viral associated disease in weaned pigs in Indiana. Veterinary Pathology. 35: 303-7. PMID 9684976 DOI: 10.1177/030098589803500411 |
0.335 |
|
| 1997 |
Papp Z, Middleton DM, Mittal SK, Babiuk LA, Baca-Estrada ME. Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection. The Journal of General Virology. 2933-43. PMID 9367381 DOI: 10.1099/0022-1317-78-11-2933 |
0.429 |
|
| 1996 |
Mittal SK, Papp Z, Tikoo SK, Baca-Estrada ME, Yoo D, Benko M, Babiuk LA. Induction of systemic and mucosa[ immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD Virology. 222: 299-309. PMID 8806514 DOI: 10.1006/Viro.1996.0427 |
0.411 |
|
| 1996 |
Mittal SK, Middleton DM, Tikoo SK, Prevec L, Graham FL, Babiuk LA. Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene Journal of General Virology. 77: 1-9. PMID 8558115 DOI: 10.1099/0022-1317-77-1-1 |
0.388 |
|
| 1995 |
Mittal SK, Prevec L, Graham FL, Babiuk LA. Development of a bovine adenovirus type 3-based expression vector Journal of General Virology. 76: 93-102. PMID 7844546 DOI: 10.1099/0022-1317-76-1-93 |
0.429 |
|
| 1995 |
Mittal SK, Bett AJ, Prevec L, Graham FL. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters. Virology. 210: 226-30. PMID 7793076 DOI: 10.1006/Viro.1995.1337 |
0.37 |
|
| 1995 |
Breker-Klassen MM, Yoo D, Mittal SK, Sorden SD, Haines DM, Babiuk LA. Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection Journal of Virology. 69: 4308-4315. PMID 7769692 DOI: 10.1128/Jvi.69.7.4308-4315.1995 |
0.395 |
|
| 1995 |
Mittal SK, Middleton DM, Tikoo SK, Babiuk LA. Pathogenesis and Immunogenicity of Bovine Adenovirus Type 3 in Cotton Rats (Sigmodon hispidus) Virology. 213: 131-139. PMID 7483256 DOI: 10.1006/Viro.1995.1553 |
0.374 |
|
| 1994 |
Zheng B, Mittal SK, Graham FL, Prevec L. The E1 sequence of bovine adenovirus type 3 and complementation of human adenovirus type 5 E1A function in bovine cells. Virus Research. 31: 163-86. PMID 8178572 DOI: 10.1016/0168-1702(94)90002-7 |
0.304 |
|
| 1993 |
Mittal SK, McDermott MR, Johnson DC, Prevec L, Graham FL. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research. 28: 67-90. PMID 8388142 DOI: 10.1016/0168-1702(93)90090-A |
0.349 |
|
| Show low-probability matches. |